Biostate AI closes $12M to bring the Netflix model to molecular diagnostics

Houston, May 20, 2025 (GLOBE NEWSWIRE) -- Biostate AI, a leading innovator in artificial intelligence and RNA sequencing, announced the successful completion of a $12M Series A funding round, led by Accel. Additional investors included Gaingels, Mana Ventures, InfoEdge Ventures, and existing investors Matter Venture Partners, Vision Plus Capital, and Catapult Ventures. The company's seed round also attracted notable angel investors, including Dario Amodei (CEO, Anthropic), Mike Schnall-Levin (CTO, 10x Genom ...